Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YY001 in upper limb spasticity
NCT06783114Phase 3Recruiting
- Sponsor
- Claruvis Pharmaceutical
- Start
- Sep 2024
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of YY001 in Upper limb spasticity, sponsored by Claruvis Pharmaceutical. Started Sep 2024; status: recruiting.
02
Drugs
YY001
03
Conditions
Upper limb spasticity
Beyond the preview
Go deeper on NCT06783114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06783114.